4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001714899-23-000015
Director sold 2,970 shares at $28.44 ($84,467)
From the SEC's structured data for this filing
Trades in this filing
Krognes Steve E. · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-01-05 | Sale : show line 1 in the form | −2,970 | $28.44 | $84,467 | 146,498 | D |
| Open-market sales · 2,970 sh · avg $28.44 · $84,467 | ||||||
Loading xslF345X03/wf-form4_167331855351574.xml…